Global Systemic Anti-Infectives Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Report ID: GIR2212260091 | Category: Pharma & Healthcare | Pages: 121 | Format: PDF | Published Date: February 03,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

Anti-infective drugs are drugs that have the effect of killing or inhibiting the above pathogenic microorganisms and are applied systemically or topically by oral, intramuscular, intravenous or topical application. Systemic anti-infective drugs are the basic drugs and are widely used in the treatment of bacterial, fungal, chlamydial and viral infections and other infectious complications arising from other diseases.
According to our (Global Info Research) latest study, the global Systemic Anti-Infectives market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Systemic Anti-Infectives market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Systemic Anti-Infectives market size and forecasts, in consumption value ($ Million), 2018-2029
Global Systemic Anti-Infectives market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Systemic Anti-Infectives market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Systemic Anti-Infectives market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Systemic Anti-Infectives
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Systemic Anti-Infectives market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Sumitomo Dainippon Pharma, MSD, Bayer and Bristol-Myers Squibb, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Systemic Anti-Infectives market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Injections
    Tablets
    Capsules & Pellets
    Others
Market segment by Application
    Hospital
    Clinic
    Drugstores
    Others
Market segment by players, this report covers
    Pfizer
    Sumitomo Dainippon Pharma
    MSD
    Bayer
    Bristol-Myers Squibb
    Dechra
    Alandalous
    Chiatai Tianqing
    Hailing Pharm
    Southwest Pharmaceutical Co., Ltd.
    Guangzhou Baiyunshan
    Harbin Pharmaceutical Group
    CSPC Pharmaceutical
    North China Pharmaceutical
    Sinopharm
    Luoxin Pharmaceutical
    CR Pharma
    Duopharma Biotech Group
    PT Infion Pharma
    Bright-gene
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Systemic Anti-Infectives product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Systemic Anti-Infectives, with revenue, gross margin and global market share of Systemic Anti-Infectives from 2018 to 2023.
Chapter 3, the Systemic Anti-Infectives competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Systemic Anti-Infectives market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Systemic Anti-Infectives.
Chapter 13, to describe Systemic Anti-Infectives research findings and conclusion.

1 Market Overview
    1.1 Product Overview and Scope of Systemic Anti-Infectives
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Systemic Anti-Infectives by Type
        1.3.1 Overview: Global Systemic Anti-Infectives Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Systemic Anti-Infectives Consumption Value Market Share by Type in 2022
        1.3.3 Injections
        1.3.4 Tablets
        1.3.5 Capsules & Pellets
        1.3.6 Others
    1.4 Global Systemic Anti-Infectives Market by Application
        1.4.1 Overview: Global Systemic Anti-Infectives Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital
        1.4.3 Clinic
        1.4.4 Drugstores
        1.4.5 Others
    1.5 Global Systemic Anti-Infectives Market Size & Forecast
    1.6 Global Systemic Anti-Infectives Market Size and Forecast by Region
        1.6.1 Global Systemic Anti-Infectives Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Systemic Anti-Infectives Market Size by Region, (2018-2029)
        1.6.3 North America Systemic Anti-Infectives Market Size and Prospect (2018-2029)
        1.6.4 Europe Systemic Anti-Infectives Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Systemic Anti-Infectives Market Size and Prospect (2018-2029)
        1.6.6 South America Systemic Anti-Infectives Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Systemic Anti-Infectives Market Size and Prospect (2018-2029)
2 Company Profiles
    2.1 Pfizer
        2.1.1 Pfizer Details
        2.1.2 Pfizer Major Business
        2.1.3 Pfizer Systemic Anti-Infectives Product and Solutions
        2.1.4 Pfizer Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Pfizer Recent Developments and Future Plans
    2.2 Sumitomo Dainippon Pharma
        2.2.1 Sumitomo Dainippon Pharma Details
        2.2.2 Sumitomo Dainippon Pharma Major Business
        2.2.3 Sumitomo Dainippon Pharma Systemic Anti-Infectives Product and Solutions
        2.2.4 Sumitomo Dainippon Pharma Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Sumitomo Dainippon Pharma Recent Developments and Future Plans
    2.3 MSD
        2.3.1 MSD Details
        2.3.2 MSD Major Business
        2.3.3 MSD Systemic Anti-Infectives Product and Solutions
        2.3.4 MSD Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 MSD Recent Developments and Future Plans
    2.4 Bayer
        2.4.1 Bayer Details
        2.4.2 Bayer Major Business
        2.4.3 Bayer Systemic Anti-Infectives Product and Solutions
        2.4.4 Bayer Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Bayer Recent Developments and Future Plans
    2.5 Bristol-Myers Squibb
        2.5.1 Bristol-Myers Squibb Details
        2.5.2 Bristol-Myers Squibb Major Business
        2.5.3 Bristol-Myers Squibb Systemic Anti-Infectives Product and Solutions
        2.5.4 Bristol-Myers Squibb Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.6 Dechra
        2.6.1 Dechra Details
        2.6.2 Dechra Major Business
        2.6.3 Dechra Systemic Anti-Infectives Product and Solutions
        2.6.4 Dechra Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Dechra Recent Developments and Future Plans
    2.7 Alandalous
        2.7.1 Alandalous Details
        2.7.2 Alandalous Major Business
        2.7.3 Alandalous Systemic Anti-Infectives Product and Solutions
        2.7.4 Alandalous Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Alandalous Recent Developments and Future Plans
    2.8 Chiatai Tianqing
        2.8.1 Chiatai Tianqing Details
        2.8.2 Chiatai Tianqing Major Business
        2.8.3 Chiatai Tianqing Systemic Anti-Infectives Product and Solutions
        2.8.4 Chiatai Tianqing Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Chiatai Tianqing Recent Developments and Future Plans
    2.9 Hailing Pharm
        2.9.1 Hailing Pharm Details
        2.9.2 Hailing Pharm Major Business
        2.9.3 Hailing Pharm Systemic Anti-Infectives Product and Solutions
        2.9.4 Hailing Pharm Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Hailing Pharm Recent Developments and Future Plans
    2.10 Southwest Pharmaceutical Co., Ltd. 
        2.10.1 Southwest Pharmaceutical Co., Ltd. Details
        2.10.2 Southwest Pharmaceutical Co., Ltd. Major Business
        2.10.3 Southwest Pharmaceutical Co., Ltd. Systemic Anti-Infectives Product and Solutions
        2.10.4 Southwest Pharmaceutical Co., Ltd. Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Southwest Pharmaceutical Co., Ltd. Recent Developments and Future Plans
    2.11 Guangzhou Baiyunshan
        2.11.1 Guangzhou Baiyunshan Details
        2.11.2 Guangzhou Baiyunshan Major Business
        2.11.3 Guangzhou Baiyunshan Systemic Anti-Infectives Product and Solutions
        2.11.4 Guangzhou Baiyunshan Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Guangzhou Baiyunshan Recent Developments and Future Plans
    2.12 Harbin Pharmaceutical Group
        2.12.1 Harbin Pharmaceutical Group Details
        2.12.2 Harbin Pharmaceutical Group Major Business
        2.12.3 Harbin Pharmaceutical Group Systemic Anti-Infectives Product and Solutions
        2.12.4 Harbin Pharmaceutical Group Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Harbin Pharmaceutical Group Recent Developments and Future Plans
    2.13 CSPC Pharmaceutical
        2.13.1 CSPC Pharmaceutical Details
        2.13.2 CSPC Pharmaceutical Major Business
        2.13.3 CSPC Pharmaceutical Systemic Anti-Infectives Product and Solutions
        2.13.4 CSPC Pharmaceutical Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 CSPC Pharmaceutical Recent Developments and Future Plans
    2.14 North China Pharmaceutical
        2.14.1 North China Pharmaceutical Details
        2.14.2 North China Pharmaceutical Major Business
        2.14.3 North China Pharmaceutical Systemic Anti-Infectives Product and Solutions
        2.14.4 North China Pharmaceutical Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 North China Pharmaceutical Recent Developments and Future Plans
    2.15 Sinopharm
        2.15.1 Sinopharm Details
        2.15.2 Sinopharm Major Business
        2.15.3 Sinopharm Systemic Anti-Infectives Product and Solutions
        2.15.4 Sinopharm Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Sinopharm Recent Developments and Future Plans
    2.16 Luoxin Pharmaceutical
        2.16.1 Luoxin Pharmaceutical Details
        2.16.2 Luoxin Pharmaceutical Major Business
        2.16.3 Luoxin Pharmaceutical Systemic Anti-Infectives Product and Solutions
        2.16.4 Luoxin Pharmaceutical Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Luoxin Pharmaceutical Recent Developments and Future Plans
    2.17 CR Pharma
        2.17.1 CR Pharma Details
        2.17.2 CR Pharma Major Business
        2.17.3 CR Pharma Systemic Anti-Infectives Product and Solutions
        2.17.4 CR Pharma Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 CR Pharma Recent Developments and Future Plans
    2.18 Duopharma Biotech Group
        2.18.1 Duopharma Biotech Group Details
        2.18.2 Duopharma Biotech Group Major Business
        2.18.3 Duopharma Biotech Group Systemic Anti-Infectives Product and Solutions
        2.18.4 Duopharma Biotech Group Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.18.5 Duopharma Biotech Group Recent Developments and Future Plans
    2.19 PT Infion Pharma
        2.19.1 PT Infion Pharma Details
        2.19.2 PT Infion Pharma Major Business
        2.19.3 PT Infion Pharma Systemic Anti-Infectives Product and Solutions
        2.19.4 PT Infion Pharma Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.19.5 PT Infion Pharma Recent Developments and Future Plans
    2.20 Bright-gene
        2.20.1 Bright-gene Details
        2.20.2 Bright-gene Major Business
        2.20.3 Bright-gene Systemic Anti-Infectives Product and Solutions
        2.20.4 Bright-gene Systemic Anti-Infectives Revenue, Gross Margin and Market Share (2018-2023)
        2.20.5 Bright-gene Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Systemic Anti-Infectives Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Systemic Anti-Infectives by Company Revenue
        3.2.2 Top 3 Systemic Anti-Infectives Players Market Share in 2022
        3.2.3 Top 6 Systemic Anti-Infectives Players Market Share in 2022
    3.3 Systemic Anti-Infectives Market: Overall Company Footprint Analysis
        3.3.1 Systemic Anti-Infectives Market: Region Footprint
        3.3.2 Systemic Anti-Infectives Market: Company Product Type Footprint
        3.3.3 Systemic Anti-Infectives Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
    4.1 Global Systemic Anti-Infectives Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Systemic Anti-Infectives Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
    5.1 Global Systemic Anti-Infectives Consumption Value Market Share by Application (2018-2023)
    5.2 Global Systemic Anti-Infectives Market Forecast by Application (2024-2029)
6 North America
    6.1 North America Systemic Anti-Infectives Consumption Value by Type (2018-2029)
    6.2 North America Systemic Anti-Infectives Consumption Value by Application (2018-2029)
    6.3 North America Systemic Anti-Infectives Market Size by Country
        6.3.1 North America Systemic Anti-Infectives Consumption Value by Country (2018-2029)
        6.3.2 United States Systemic Anti-Infectives Market Size and Forecast (2018-2029)
        6.3.3 Canada Systemic Anti-Infectives Market Size and Forecast (2018-2029)
        6.3.4 Mexico Systemic Anti-Infectives Market Size and Forecast (2018-2029)
7 Europe
    7.1 Europe Systemic Anti-Infectives Consumption Value by Type (2018-2029)
    7.2 Europe Systemic Anti-Infectives Consumption Value by Application (2018-2029)
    7.3 Europe Systemic Anti-Infectives Market Size by Country
        7.3.1 Europe Systemic Anti-Infectives Consumption Value by Country (2018-2029)
        7.3.2 Germany Systemic Anti-Infectives Market Size and Forecast (2018-2029)
        7.3.3 France Systemic Anti-Infectives Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Systemic Anti-Infectives Market Size and Forecast (2018-2029)
        7.3.5 Russia Systemic Anti-Infectives Market Size and Forecast (2018-2029)
        7.3.6 Italy Systemic Anti-Infectives Market Size and Forecast (2018-2029)
8 Asia-Pacific
    8.1 Asia-Pacific Systemic Anti-Infectives Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Systemic Anti-Infectives Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Systemic Anti-Infectives Market Size by Region
        8.3.1 Asia-Pacific Systemic Anti-Infectives Consumption Value by Region (2018-2029)
        8.3.2 China Systemic Anti-Infectives Market Size and Forecast (2018-2029)
        8.3.3 Japan Systemic Anti-Infectives Market Size and Forecast (2018-2029)
        8.3.4 South Korea Systemic Anti-Infectives Market Size and Forecast (2018-2029)
        8.3.5 India Systemic Anti-Infectives Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Systemic Anti-Infectives Market Size and Forecast (2018-2029)
        8.3.7 Australia Systemic Anti-Infectives Market Size and Forecast (2018-2029)
9 South America
    9.1 South America Systemic Anti-Infectives Consumption Value by Type (2018-2029)
    9.2 South America Systemic Anti-Infectives Consumption Value by Application (2018-2029)
    9.3 South America Systemic Anti-Infectives Market Size by Country
        9.3.1 South America Systemic Anti-Infectives Consumption Value by Country (2018-2029)
        9.3.2 Brazil Systemic Anti-Infectives Market Size and Forecast (2018-2029)
        9.3.3 Argentina Systemic Anti-Infectives Market Size and Forecast (2018-2029)
10 Middle East & Africa
    10.1 Middle East & Africa Systemic Anti-Infectives Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Systemic Anti-Infectives Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Systemic Anti-Infectives Market Size by Country
        10.3.1 Middle East & Africa Systemic Anti-Infectives Consumption Value by Country (2018-2029)
        10.3.2 Turkey Systemic Anti-Infectives Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Systemic Anti-Infectives Market Size and Forecast (2018-2029)
        10.3.4 UAE Systemic Anti-Infectives Market Size and Forecast (2018-2029)
11 Market Dynamics
    11.1 Systemic Anti-Infectives Market Drivers
    11.2 Systemic Anti-Infectives Market Restraints
    11.3 Systemic Anti-Infectives Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
    12.1 Systemic Anti-Infectives Industry Chain
    12.2 Systemic Anti-Infectives Upstream Analysis
    12.3 Systemic Anti-Infectives Midstream Analysis
    12.4 Systemic Anti-Infectives Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Systemic Anti-Infectives Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?